ARDELYX, INC. Shares Issued
ARDELYX, INC. (ARDX) had Shares Issued of 249.15 million shares as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Equity › Common Stock, Number of Shares, Par Value and Other Disclosure
us-gaap:CommonStockSharesIssued · last filed 2026-08-06
- 2026-06-30: Common Stock, Shares, Issued 249.15M shares.
- 2026-03-31: Common Stock, Shares, Issued 246.97M shares.
- 2025-12-31: Common Stock, Shares, Issued 244.35M shares.
- 2025-09-30: Common Stock, Shares, Issued 242.97M shares.
| Period end | Common Stock, Shares, Issued | Common Stock, Shares, Issued as first filed |
|---|---|---|
| 2026-06-30 | 249.15M shares 10-Q · filed 2026-08-06 | |
| 2026-03-31 | 246.97M shares 10-Q · filed 2026-04-30 | |
| 2025-12-31 | 244.35M shares 10-Q · filed 2026-08-06 | |
| 2025-09-30 | 242.97M shares 10-Q · filed 2025-10-30 | |
| 2025-06-30 | 240.77M shares 10-Q · filed 2025-08-04 | |
| 2025-03-31 | 239.20M shares 10-Q · filed 2025-05-01 | |
| 2024-12-31 | 238.02M shares 10-K · filed 2026-02-19 | |
| 2024-09-30 | 236.89M shares 10-Q · filed 2024-10-31 | |
| 2024-06-30 | 235.40M shares 10-Q · filed 2024-08-01 | |
| 2024-03-31 | 233.96M shares 10-Q · filed 2024-05-02 | |
| 2023-12-31 | 232.45M shares 10-K · filed 2025-02-20 | |
| 2023-09-30 | 232.13M shares 10-Q · filed 2023-10-31 | |
| 2023-06-30 | 217.86M shares 10-Q · filed 2023-08-02 | |
| 2023-03-31 | 214.46M shares 10-Q · filed 2023-05-03 | |
| 2022-12-31 | 198.58M shares 10-K · filed 2024-02-22 | |
| 2022-09-30 | 187.40M shares 10-Q · filed 2022-11-03 | |
| 2022-06-30 | 153.80M shares 10-Q · filed 2022-08-04 | |
| 2022-03-31 | 136.33M shares 10-Q · filed 2022-05-05 | |
| 2021-12-31 | 130.18M shares 10-K · filed 2023-03-02 | |
| 2021-09-30 | 106.77M shares 10-Q · filed 2021-11-12 | |
| 2021-06-30 | 102.97M shares 10-Q · filed 2021-08-13 | |
| 2021-03-31 | 98.69M shares 10-Q · filed 2021-05-06 | |
| 2020-12-31 | 93.60M shares 10-K · filed 2022-02-28 | |
| 2020-09-30 | 90.24M shares 10-Q · filed 2020-11-05 | |
| 2020-06-30 | 89.14M shares 10-Q · filed 2020-08-06 | |
| 2020-03-31 | 89.04M shares 10-Q · filed 2020-05-07 | |
| 2019-12-31 | 88.82M shares 10-K · filed 2021-03-08 | |
| 2019-09-30 | 62.88M shares 10-Q · filed 2019-11-06 | |
| 2019-06-30 | 62.80M shares 10-Q · filed 2019-08-09 | |
| 2019-03-31 | 62.60M shares 10-Q · filed 2019-05-07 | |
| 2018-12-31 | 62.52M shares 10-K · filed 2020-03-06 | |
| 2018-09-30 | 62.11M shares 10-Q · filed 2018-11-07 | |
| 2018-06-30 | 62.05M shares 10-Q · filed 2018-08-07 | |
| 2018-06-25 | 14.38M shares 10-Q · filed 2019-05-07 | |
| 2018-05-25 | 14.40 shares 10-K · filed 2021-03-08 | 14.38M shares 10-K · filed 2020-03-06 |
| 2018-03-31 | 47.60M shares 10-Q · filed 2018-05-08 | |
| 2017-12-31 | 47.53M shares 10-K · filed 2019-03-06 | |
| 2017-09-30 | 47.50M shares 10-Q · filed 2017-11-07 | |
| 2017-06-30 | 47.44M shares 10-Q · filed 2017-08-09 | |
| 2017-03-31 | 47.39M shares 10-Q · filed 2017-05-05 | |
| 2016-12-31 | 47.31M shares 10-K · filed 2018-03-14 | |
| 2016-09-30 | 47.30M shares 10-Q · filed 2016-11-07 | |
| 2016-06-30 | 34.65M shares 10-Q · filed 2016-08-08 | |
| 2016-03-31 | 34.63M shares 10-Q · filed 2016-05-09 | |
| 2015-12-31 | 25.96M shares 10-K · filed 2017-02-17 | |
| 2015-09-30 | 25.95M shares 10-Q · filed 2015-11-12 | |
| 2015-06-30 | 25.91M shares 10-Q · filed 2015-08-12 | |
| 2015-03-31 | 18.64M shares 10-Q · filed 2015-05-12 | |
| 2014-12-31 | 18.59M shares 10-K · filed 2016-03-04 | |
| 2014-09-30 | 18.40M shares 10-Q · filed 2014-11-07 | |
| 2014-06-30 | 18.34M shares 10-Q · filed 2014-08-08 | |
| 2013-12-31 | 1.23M shares 10-K · filed 2015-03-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Cryoport, Inc. (CYRX) | United States | $0.881B | -21.29 |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |